02 Sep Aegis Sciences Corporation and QURE Announce Groundbreaking Results from InterACT Rx™
Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs resulting in improved patient...
Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs resulting in improved patient...
NASHVILLE, TN (September 1, 2020) - Aegis Sciences Corporation is pleased to announce that effective September 1, 2020 we will be...
Today, the U.S. Department of Health and Human Services announced combined investments of $6.5 million in two commercial diagnostic laboratories...
NASHVILLE, Tenn., (June 09, 2020) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing...
Nashville, Tennessee (June 8, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and...
Nashville, Tennessee (May 6, 2020) – Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and...